Cargando…
Cardiovascular complications of COVID-19
The emergence of the novel SARS coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has resulted in an unprecedented pandemic that has been accompanied by a global health crisis. Although the lungs are the main organs involved in COVID-19, systemic disease with a...
Autores principales: | Farshidfar, Farnaz, Koleini, Navid, Ardehali, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410051/ https://www.ncbi.nlm.nih.gov/pubmed/34061779 http://dx.doi.org/10.1172/jci.insight.148980 |
Ejemplares similares
-
Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
por: Koleini, Navid, et al.
Publicado: (2017) -
Role of Heme in Cardiovascular Physiology and Disease
por: Sawicki, Konrad Teodor, et al.
Publicado: (2015) -
The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease
por: Fang, Xuexian, et al.
Publicado: (2022) -
COVID-19-Associated Cardiovascular Complications
por: Lee, Clement C. E., et al.
Publicado: (2021) -
[WITHDRAWN] Hexokinase-1 mitochondrial dissociation and protein O-GlcNAcylation drive heart failure with preserved ejection fraction
por: Tatekoshi, Yuki, et al.
Publicado: (2023)